Pharmacokinetics of oral <i>vs</i>. intravenous dexamethasone in patients hospitalized with community‐acquired pneumonia
Simone M.C. Spoorenberg(St. Antonius Ziekenhuis), E.M.W. van de Garde(Utrecht University), Willem Jan W. Bos(St. Antonius Ziekenhuis), G. Paul Voorn(St. Antonius Ziekenhuis), Astrid E. Pulles(University Hospital Heidelberg), Ger T. Rijkers(Roosevelt University), Jan C. Grutters(St. Antonius Ziekenhuis), Vera H.M. Deneer(St. Antonius Ziekenhuis)
Cited by 95
Related Papers
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
|The Lancet|2023|508
Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial
|The Lancet|2011|372
Reconstruction of Brachial Artery Pressure From Noninvasive Finger Pressure Measurements
|Circulation|1996|363
Accuracy of Cuff-Measured Blood Pressure
|Journal of the American College of Cardiology|2017|271
Comparative Survival among Older Adults with Advanced Kidney Disease Managed Conservatively Versus with Dialysis
|Clinical Journal of the American Society of Nephrology|2016|260